The concept of a differential and diversified role of the Insulin receptor and the IGF1R towards controlling growth, aging- and cancer-related effects also comes from the recent observation that the IR but not the IGF1R are under the phylogenetic control of a specific ubiquitin-linked degradative system regulating its steady-state protein level in C.Elegans [48]. The gene discussed is INSR; the disease is cancer.